Xiaogang Xiang

1.8k total citations
61 papers, 1.3k citations indexed

About

Xiaogang Xiang is a scholar working on Epidemiology, Hepatology and Pharmacology. According to data from OpenAlex, Xiaogang Xiang has authored 61 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Epidemiology, 31 papers in Hepatology and 9 papers in Pharmacology. Recurrent topics in Xiaogang Xiang's work include Liver Disease Diagnosis and Treatment (38 papers), Hepatitis B Virus Studies (27 papers) and Hepatitis C virus research (15 papers). Xiaogang Xiang is often cited by papers focused on Liver Disease Diagnosis and Treatment (38 papers), Hepatitis B Virus Studies (27 papers) and Hepatitis C virus research (15 papers). Xiaogang Xiang collaborates with scholars based in China, Australia and United States. Xiaogang Xiang's co-authors include Qing Xie, Bin Gao, Hui Wang, Dechun Feng, Shisan Bao, Seonghwan Hwang, Yong He, Ruidong Mo, Zhujun Cao and Tianyi Ren and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Hepatology.

In The Last Decade

Xiaogang Xiang

57 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaogang Xiang China 21 739 507 261 246 167 61 1.3k
Nirupama Trehanpati India 15 618 0.8× 635 1.3× 214 0.8× 115 0.5× 152 0.9× 27 1.1k
Yedidya Saiman United States 14 767 1.0× 798 1.6× 282 1.1× 180 0.7× 90 0.5× 22 1.4k
Émilie Crouchet France 10 727 1.0× 710 1.4× 296 1.1× 109 0.4× 92 0.6× 17 1.2k
Jana C. Mossanen Germany 13 662 0.9× 557 1.1× 304 1.2× 442 1.8× 305 1.8× 22 1.5k
Tobias Puengel Germany 14 1.0k 1.4× 638 1.3× 395 1.5× 345 1.4× 123 0.7× 29 1.6k
Yanhang Gao China 14 643 0.9× 344 0.7× 352 1.3× 166 0.7× 60 0.4× 37 1.1k
Anke Liepelt Germany 12 502 0.7× 402 0.8× 292 1.1× 395 1.6× 102 0.6× 15 1.2k
Miriam Ruth Bueno‐Topete Mexico 17 327 0.4× 330 0.7× 263 1.0× 148 0.6× 53 0.3× 45 870
Ludger Leifeld Germany 26 810 1.1× 824 1.6× 227 0.9× 528 2.1× 184 1.1× 73 2.1k

Countries citing papers authored by Xiaogang Xiang

Since Specialization
Citations

This map shows the geographic impact of Xiaogang Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaogang Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaogang Xiang more than expected).

Fields of papers citing papers by Xiaogang Xiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaogang Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaogang Xiang. The network helps show where Xiaogang Xiang may publish in the future.

Co-authorship network of co-authors of Xiaogang Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaogang Xiang. A scholar is included among the top collaborators of Xiaogang Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaogang Xiang. Xiaogang Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Zhujun, Yuhan Liu, Haiguang Xin, et al.. (2024). Blood markers for type-1, -2, and -3 inflammation are associated with severity of acutely decompensated cirrhosis. Journal of Hepatology. 82(5). 836–850. 3 indexed citations
2.
Feng, Dechun, Xiaogang Xiang, Yukun Guan, et al.. (2023). Monocyte-derived macrophages orchestrate multiple cell-type interactions to repair necrotic liver lesions in disease models. Journal of Clinical Investigation. 133(15). 56 indexed citations
3.
Lai, Rongtao, Yan Huang, Ruidong Mo, et al.. (2023). Clinic-radiomics model using liver magnetic resonance imaging helps predict chronicity of drug-induced liver injury. Hepatology International. 17(6). 1626–1636. 3 indexed citations
4.
Guo, Mingzhe, Jie Lu, Xiaogang Xiang, et al.. (2023). Construction and characterization of a new hepatitis C virus genotype 6a subgenomic replicon that is prone to render the sofosbuvir resistance. Journal of Medical Virology. 95(9). e29103–e29103.
5.
Cao, Zhujun, Zi-Ke Sheng, Xiaogang Xiang, et al.. (2022). COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status. Infectious Diseases of Poverty. 11(1). 56–56. 12 indexed citations
6.
Wang, Peng, Weiliang Tang, Ruidong Mo, et al.. (2022). Genetic Variations of ALDH (rs671) Are Associated With the Persistence of HBV Infection Among the Chinese Han Population. Frontiers in Medicine. 9. 811639–811639. 8 indexed citations
7.
Zhang, Jinming, Jing Xu, Weiliang Tang, et al.. (2022). Clinical characteristics and pathogen spectra of parasitic infections in a tertiary hospital of Shanghai: A 13-year retrospective study. Frontiers in Public Health. 10. 993377–993377. 3 indexed citations
8.
Fan, Qin, Hongling Zhu, Jiaxin Zhao, et al.. (2020). Risk Factors for Myocardial Injury in Patients with Coronavirus Disease 2019 in China. ESC Heart Failure. 7(6). 4108–4117. 17 indexed citations
9.
Cao, Zhujun, Yuhan Liu, Yumin Xu, et al.. (2020). The Use of NACSELD and EASL-CLIF Classification Systems of ACLF in the Prediction of Prognosis in Hospitalized Patients With Cirrhosis. The American Journal of Gastroenterology. 115(12). 2026–2035. 33 indexed citations
10.
Chen, Liwen, Zhujun Cao, Lei Yan, et al.. (2020). Circulating Receptor-Interacting Protein Kinase 3 Are Increased in HBV Patients With Acute-on-Chronic Liver Failure and Are Associated With Clinical Outcome. Frontiers in Physiology. 11. 526–526. 12 indexed citations
11.
Xu, Yumin, Zhujun Cao, Ziqiang Li, et al.. (2019). Long Non-coding RNA NEAT1 Alleviates Acute-on-Chronic Liver Failure Through Blocking TRAF6 Mediated Inflammatory Response. Frontiers in Physiology. 10. 1503–1503. 16 indexed citations
12.
Guo, Mingzhe, Jie Lu, Xiaogang Xiang, et al.. (2019). Construction and characterization of Genotype-3 hepatitis C virus replicon revealed critical genotype-3-specific polymorphism for drug resistance and viral fitness. Antiviral Research. 171. 104612–104612. 5 indexed citations
13.
Chen, Liwen, Chuanwu Zhu, Fengdi Li, et al.. (2018). Correlation between hepatic human males absent on the first (hMOF) and viral persistence in chronic hepatitis B patients. Cell & Bioscience. 8(1). 14–14. 3 indexed citations
14.
Gao, Bin, Jing Ma, & Xiaogang Xiang. (2017). MAIT cells: a novel therapeutic target for alcoholic liver disease?. Gut. 67(5). 784–786. 17 indexed citations
15.
Cao, Zhujun, Ziqiang Li, Hui Wang, et al.. (2017). Algorithm of Golgi protein 73 and liver stiffness accurately diagnoses significant fibrosis in chronic HBV infection. Liver International. 37(11). 1612–1621. 41 indexed citations
16.
Cao, Zhujun, Y. Wang, Yue Liu, et al.. (2017). Assessment of serum Golgi protein 73 as a biomarker for the diagnosis of significant fibrosis in patients with chronic HBV infection. Journal of Viral Hepatitis. 24(S1). 57–65. 26 indexed citations
17.
Mo, Ruidong, Peng Wang, Rongtao Lai, et al.. (2016). Persistently elevated circulating Th22 reversely correlates with prognosis in HBV‐related acute‐on‐chronic liver failure. Journal of Gastroenterology and Hepatology. 32(3). 677–686. 23 indexed citations
18.
19.
Xu, Yumin, Hui Wang, Fazal H. Tabassam, et al.. (2013). Amelioration of Liver Injury by Continuously Targeted Intervention against TNFRp55 in Rats with Acute-on-Chronic Liver Failure. PLoS ONE. 8(7). e68757–e68757. 17 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nirupama Trehanpati Breakdown of academic impact, for papers by Yedidya Saiman Breakdown of academic impact, for papers by Émilie Crouchet Breakdown of academic impact, for papers by Jana C. Mossanen Breakdown of academic impact, for papers by Tobias Puengel Breakdown of academic impact, for papers by Yanhang Gao Breakdown of academic impact, for papers by Anke Liepelt Breakdown of academic impact, for papers by Miriam Ruth Bueno‐Topete Breakdown of academic impact, for papers by Ludger Leifeld
Rankless by CCL
2026